Grant: Operating Grant - E-Rare-2 Joint Transnational Call on Rare Diseases
McGill University
$325,000.00
CLC chloride channels and Megalencephalic leukoencephalopathy: molecular mechanisms and therapeutics
FY 2013-14
Summary
Glial cells play a central role in brain water and ion homeostasis and the maintenance of low extracellular potassium during neuron cell activity. These functions are impaired in a rare type of leukodystrophy called MLC (megalencephalic leukoencephalopathy with subcortical cysts). Mutations in MLC1, the first gene defective in MLC, impair the cell surface expression of the MLC1 and reduce the activity of volume-regulated chloride channels (VRAC). We have established a subset of biochemical and functional interactions among the VRAC, the ClC-2 chloride channel, GlialCAM (the second gene defective in MLC) and MLC1, which likely represent components involved in the regulation of glial cell water homeostasis and chloride fluxes. Using state-of-the-art biochemical and cellular assays, as well as novel knockout mouse and zebrafish models, we will decipher the relationships between the VRAC and ClC-2 chloride channels and the MLC-defective proteins MLC1 and GlialCAM. In addition, we will identify the components of the cellular quality control mechanisms that prematurely degrade MLC1 mutants either at the ER or cell surface. We plan to perform novel genetic and chemical screens in order to identify pharmacological chaperones that restore the MLC1 mutant cell surface expression/function and could be used as therapies for MLC. This project will be instrumental to gain insights into the pathophysiology of MLC disease and other brain defects in fluid homeostasis, hopefully providing the first therapeutic solutions for MLC patients.
Department
Program
Operating Grant - E-Rare-2 Joint Transnational Call on Rare Diseases
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
288531
Name
Lukacs Gergely L
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
German Federal Ministry of Research, Technology and Space (Berlin); Fonds de recherche du Québec - Santé (FRQS); Instituto de Salud Carloss III (Spain)
Instname2
Genetics
Theme2
Biomedical
Prcname2
Special Cases
Projecttitle
CLC chloride channels and Megalencephalic leukoencephalopathy: molecular mechanisms and therapeutics
Programtype2
Operating Grants
Orgnameinp2
McGill University
Cihramount2
$325,000
Cihrequipment2
$0
Programname2
Operating Grant - E-Rare-2 Joint Transnational Call on Rare Diseases
Keyworddelim
Chloride Transport; Conformational Disease; Glial Cell; Leukodystrophy; Quality Control; Ubiquitination; Water Homeostasis
Abstract
Glial cells play a central role in brain water and ion homeostasis and the maintenance of low extracellular potassium during neuron cell activity. These functions are impaired in a rare type of leukodystrophy called MLC (megalencephalic leukoencephalopathy with subcortical cysts). Mutations in MLC1, the first gene defective in MLC, impair the cell surface expression of the MLC1 and reduce the activity of volume-regulated chloride channels (VRAC). We have established a subset of biochemical and functional interactions among the VRAC, the ClC-2 chloride channel, GlialCAM (the second gene defective in MLC) and MLC1, which likely represent components involved in the regulation of glial cell water homeostasis and chloride fluxes. Using state-of-the-art biochemical and cellular assays, as well as novel knockout mouse and zebrafish models, we will decipher the relationships between the VRAC and ClC-2 chloride channels and the MLC-defective proteins MLC1 and GlialCAM. In addition, we will identify the components of the cellular quality control mechanisms that prematurely degrade MLC1 mutants either at the ER or cell surface. We plan to perform novel genetic and chemical screens in order to identify pharmacological chaperones that restore the MLC1 mutant cell surface expression/function and could be used as therapies for MLC. This project will be instrumental to gain insights into the pathophysiology of MLC disease and other brain defects in fluid homeostasis, hopefully providing the first therapeutic solutions for MLC patients.
Competitiondate
201305
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Lukacs, Gergely L
Approvedterm
3 ans 0 mois
Cihrcontribution2
Institute of Genetics~ $325,000~ $0~